BillionToOne Competitors and Similar CompaniesClear all
BillionToOne's competitors and similar companies include ReCode Therapeutics and Geneticure.
 BillionToOne BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options. |  ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. | ||
Founding Date | Founding Date 2016 | Founding Date 2015 | Founding Date 2014 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Menlo Park, US HQ | Locations Menlo Park, US HQ | Locations Rochester, US HQ |
Employees | Employees 620 | Employees 1062% decrease | Employees 9 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 80m (about 6 years ago) | Latest funding round $ 1m (over 6 years ago) |
Total funding raised | Total funding raised $ 87.5m | Total funding raised $ 82m | Total funding raised $ 2.1m |
For sources of this data, please see the company profile
View Company Profiles
ReCode Therapeutics
HQ
Menlo Park, US
Employees
106↓ 2% decrease
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
View company